The line between injectables and surgery has begun to blur. A growing number of aesthetic patients are treating facelifts not as a standalone event but as the final act in a longer, layered process — one that begins months earlier with biostimulators, radiofrequency, and strategically placed filler.
Clinics across New York, London, and Paris report rising demand for what practitioners call the ‘pre-facelift runway.’ Patients receive two to three sessions of Sculptra or Radiesse — collagen-stimulating injectables — combined with ultrasound-based skin tightening, creating a stronger structural foundation for the surgery to come.
Beauty brands have taken notice, launching topical counterparts to the clinical trend. Serums and devices that claim to ‘prime’ the skin for future procedures have appeared on Sephora and Cult Beauty shelves, targeting the same demographic of proactive patients.
The shift reflects a deeper cultural recalibration around aging. Patients in their forties and fifties, raised on preventative skincare and early Botox, are approaching surgical intervention as a planned crescendo rather than a desperate last resort.
The aesthetics industry is effectively redrawing its own timeline. Where once the question was surgery or not, the new conversation is about sequencing — and for a generation accustomed to optimizing everything from sleep to nutrition, a multi-step approach to the face was perhaps inevitable.
